PURA Ongoing Covid-19 Updates Include New NOUV Dividend Info
May 08 2020 - 1:29PM
InvestorsHub NewsWire
Dallas, TX -- May 8, 2020 -- InvestorsHub
NewsWire -- Puration, Inc. (USOTC:
PURA) today confirmed the company plans to continue publishing
weekly Covid-19 updates. The company has
now published six weeks of updates and on Monday, May 11, 2020, it
plans to publish its 7th week of
updates.
The update this week included details and new
information on the company’s past spinoff of its cannabis
cultivation operation to Nouveau (NOUV)
and the planned dividend of NOUV stock to PURA shareholders.
PURA management confirmed its commitment to the success of
the spinoff and a dividend to PURA
shareholders.
The update on Monday will include more
information on plans for the spinoff to include discussions that
have started involving PURA’s cannabis cultivation spinoff working
with NCM Biotech, a subsidiary of Kali-Extracts (KALY),
to develop a proprietary cultivar for NCM Biotech’s ongoing efforts
to produce a COPD treatment from its patented cannabis extraction
process.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Oct 2024 to Nov 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Nov 2023 to Nov 2024
